Donor Stem Cell Infusions Preserve CAR-T Benefit in B-ALL Donor Stem Cell Infusions Preserve CAR-T Benefit in B-ALL

A Chinese team found that DSIs help maintain the efficacy of CAR-T therapy for patients with B-ALL who relapse after transplant. The study was published on as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news